Generation of two human induced pluripotent stem cell (hiPSC) lines derived from unrelated Marfan Syndrome patients

Juliana Borsoi1, Mariana Morato-Marques1, Fabiano de Araújo Tofoli1

  • 1National Laboratory for Embryonic Stem Cells (LaNCE), Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of São Paulo, SP 05508-090, Brazil.

Stem Cell Research
|June 1, 2021
PubMed

Insights

Researchers generated induced pluripotent stem cells (iPSCs) from Marfan Syndrome (MFS) patients with FBN1 variants. Differentiated cells showed distinct fibrillin-1 expression, suggesting varied molecular mechanisms in MFS.

Area of Science:

  • Genetics
  • Stem Cell Biology
  • Molecular Medicine

Background:

  • Marfan Syndrome (MFS) is an autosomal dominant disorder caused by FBN1 gene variants.
  • Despite full penetrance, MFS exhibits significant clinical variability.
  • Limited genotype-phenotype correlations are established for MFS.

Purpose of the Study:

  • To generate and characterize human induced pluripotent stem cell (hiPSC) lines from Marfan Syndrome patients.
  • To investigate potential differences in molecular mechanisms underlying MFS based on distinct FBN1 variants.

Main Methods:

  • hiPSCs were derived from erythroblasts of two unrelated MFS patients with heterozygous FBN1 variants.
  • Reprogramming utilized episomal vectors encoding OCT4, SOX2, KLF4, c-MYC, and LIN-28.
  • hiPSC lines were characterized using established criteria.

Main Results:

  • Successfully generated and characterized hiPSC lines from MFS patients.
  • Differentiated cells displayed differential patterns of fibrillin-1 expression.
  • Observed variations in fibrillin-1 expression suggest distinct molecular pathways in MFS.

Conclusions:

  • hiPSC technology provides a valuable model for studying MFS heterogeneity.
  • Patient-derived hiPSCs reveal differential fibrillin-1 expression patterns.
  • These findings highlight distinct molecular mechanisms contributing to Marfan Syndrome variability.